Visit Us on Facebook

  • Home
  • Resources
    • Hispanic Disparities
    • Cancer Facts & Figures
    • Emerging treatments - AI
    • Screening Benefits
    • Clinical Trials
    • FDA Approved Cancer Drugs
    • News
    • Lupus
  • Cancer Type
    • Liver Cancer
    • MPN Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Myeloma Cancer
    • Breast Cancer
    • Stomach
    • Systemic Mastocytosis
    • Prostate Cancer
    • Pancreatic Cancer
    • Uterine Cancer
  • Media
    • Videos
    • E 3 Advocacy
    • Podcasts
  • About Us
    • Mission
    • Campeón Gala 2025
    • Leadership
    • Alliances
    • Inspiration
    • Contact Us
  • Newsletter
  • More
    • Home
    • Resources
      • Hispanic Disparities
      • Cancer Facts & Figures
      • Emerging treatments - AI
      • Screening Benefits
      • Clinical Trials
      • FDA Approved Cancer Drugs
      • News
      • Lupus
    • Cancer Type
      • Liver Cancer
      • MPN Cancer
      • Colorectal Cancer
      • Lung Cancer
      • Myeloma Cancer
      • Breast Cancer
      • Stomach
      • Systemic Mastocytosis
      • Prostate Cancer
      • Pancreatic Cancer
      • Uterine Cancer
    • Media
      • Videos
      • E 3 Advocacy
      • Podcasts
    • About Us
      • Mission
      • Campeón Gala 2025
      • Leadership
      • Alliances
      • Inspiration
      • Contact Us
    • Newsletter
  • Home
  • Resources
    • Hispanic Disparities
    • Cancer Facts & Figures
    • Emerging treatments - AI
    • Screening Benefits
    • Clinical Trials
    • FDA Approved Cancer Drugs
    • News
    • Lupus
  • Cancer Type
    • Liver Cancer
    • MPN Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Myeloma Cancer
    • Breast Cancer
    • Stomach
    • Systemic Mastocytosis
    • Prostate Cancer
    • Pancreatic Cancer
    • Uterine Cancer
  • Media
    • Videos
    • E 3 Advocacy
    • Podcasts
  • About Us
    • Mission
    • Campeón Gala 2025
    • Leadership
    • Alliances
    • Inspiration
    • Contact Us
  • Newsletter
Latinx Cancer Alliance

"Saber es Poder" - Latino Cancer Disparities

"Saber es Poder" - Latino Cancer Disparities "Saber es Poder" - Latino Cancer Disparities "Saber es Poder" - Latino Cancer Disparities

Prostate Cancer

The prostate is below the bladder (the hollow organ where urine is stored) and in front of the rectum (the last part of the intestines). Just behind the prostate are glands called seminal vesicles, which make most of the fluid for semen. The urethra, which is the tube that carries urine and semen out of the body through the penis, goes through the center of the prostate.

color illustration showing the prostate and surrounding area (including the location of the urethra, penis, scrotum, rectum, bladder and seminal vesicle)

What Is Cancer?

Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer cells. Learn more here.

Anatomy Gallery: Male Genitourinary System

Explore our 3D interactive tour of the male genitourinary system.

The prostate tends to grow as a man ages. In younger men, it is about the size of a walnut, but it can be much larger in older men.

Types of prostate cancer

Almost all prostate cancers are adenocarcinomas. These cancers develop from the gland cells in the prostate (the cells that make the prostate fluid that is added to the semen).

Other types of cancer that can start in the prostate include:

  • Small cell carcinoma (small cell neuroendocrine carcinoma)
  • Other neuroendocrine tumors (including large cell carcinoma)
  • Transitional cell carcinoma
  • Sarcomas

These other types of cancer are rare. If you are told you have prostate cancer, it is very likely to be an adenocarcinoma.

Some prostate cancers can grow and spread quickly, but most tend to grow slowly. To learn more, see the information on prostate cancer grades in Tests to Diagnose and Stage Prostate Cancer.

Possible pre-cancerous conditions of the prostate

Some research suggests that prostate cancer might start out as a pre-cancerous condition in some cases. These conditions are sometimes found when a man has a prostate biopsy (removal of small pieces of the prostate to look for cancer).

Prostatic intraepithelial neoplasia (PIN)

In PIN, the prostate cells don’t look normal when seen with a microscope, but the abnormal cells don’t look like they are invading into other parts of the prostate (like cancer cells would). PIN is not cancer, but it can sometimes lead to a higher risk of prostate cancer.

Based on how the patterns of cells look, PIN is classified as either:

  • Low-grade PIN if the patterns of prostate cells appear almost normal, or
  • High-grade PIN if the patterns of cells look more abnormal

Low-grade PIN is not thought to be related to a man’s risk of prostate cancer.

If you have high-grade PIN, you may have a higher risk of developing prostate cancer over time. However, most often high-grade PIN does not turn into cancer.

Proliferative inflammatory atrophy (PIA)

In PIA, the prostate cells look smaller than normal, and there are signs of inflammation in the area. PIA is not cancer, and it’s not yet clear if PIA might lead to high-grade PIN or prostate cancer.

For more on non-cancer conditions that might be seen on a prostate biopsy, including PIN, see Tests to Diagnose and Stage Prostate Cancer.


Copyright © 2025 Latin X Cancer Alliance Inc - All Rights Reserved.

Latin X Cancer Alliance is a Registered Non Profit, 501c3 

  • Videos
  • Mission
  • Contact Us
  • Newsletter

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept